1.
Van Renne N, Wei R, Pochet N, Nauwynck HJ. Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses. BMC Genomics. 2018;19(1):831. doi:10.1186/s12864-018-5217-5.
1.
Masugi Y, Nishihara R, Hamada T, et al. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. Cancer Immunol Res. 2017;5(11):1046-1055. doi:10.1158/2326-6066.CIR-17-0122.
1.
Arazi A, Rao DA, Berthier CC, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902-914. doi:10.1038/s41590-019-0398-x.
1.
Lalani A-KA, Xie W, Martini DJ, et al. Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. J Immunother Cancer. 2018;6(1):5. doi:10.1186/s40425-018-0315-0.
1.
Clark AR, Greka A. The power of one: advances in single-cell genomics in the kidney. Nat Rev Nephrol. 2020;16(2):73-74. doi:10.1038/s41581-019-0237-1.
1.
Brown EM, Xavier RJ. Without Adaptive Immunity, There’s a Cost to Responding STAT. Cell Metab. 2018;27(4):705-707. doi:10.1016/j.cmet.2018.03.011.
1.
Bauer J, Becker AJ, Elyaman W, et al. Innate and adaptive immunity in human epilepsies. Epilepsia. 2017;58 Suppl 3:57-68. doi:10.1111/epi.13784.
1.
Lessel D, Gehbauer C, Bramswig NC, et al. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain. 2018;141(8):2299-2311. doi:10.1093/brain/awy173.
1.
Lin GL, Nagaraja S, Filbin MG, Suvà ML, Vogel H, Monje M. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun. 2018;6(1):51. doi:10.1186/s40478-018-0553-x.
1.
Ashok A, Naaz S, Kota LN, et al. Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes?. Asian J Psychiatr. 2019;39:174-177. doi:10.1016/j.ajp.2018.08.010.